Teaching NeuroImage: Severe Amyloid-Related Imaging Abnormalities After Anti-β-Amyloid Monoclonal Antibody Treatment.
作者信息
Bonomi Samuele, Samara Amjad, Balestra Noah, Padalia Arjun, Benzinger Tammie L, Kang Peter
机构信息
From the Department of Neurology (S.B., A.S., N.B., A.P., P.K.); Mallinckrodt Institute of Radiology (T.L.B.); and Knight Alzheimer Disease Research Center (T.L.B.), Washington University School of Medicine in St. Louis, St. Louis, MO.
出版信息
Neurology. 2023 Dec 4;101(23):1079-1080. doi: 10.1212/WNL.0000000000207927.
Abstract
摘要
相似文献
1
Teaching NeuroImage: Severe Amyloid-Related Imaging Abnormalities After Anti-β-Amyloid Monoclonal Antibody Treatment.教学神经影像：抗β淀粉样蛋白单克隆抗体治疗后严重的淀粉样蛋白相关影像异常
Neurology. 2023 Dec 4;101(23):1079-1080. doi: 10.1212/WNL.0000000000207927.
2
[Radiological Identification and Evaluation of Amyloid-Related Imaging Abnormalities in Alzheimer's Disease].[阿尔茨海默病中淀粉样蛋白相关影像异常的放射学识别与评估]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Nov 20;55(6):1364-1370. doi: 10.12182/20241160201.
3
Teaching NeuroImage: Cerebral Amyloid Angiopathy-Related Inflammation: An Interesting Evolution of Imaging Findings.教学神经影像学：脑淀粉样血管病相关炎症：影像学表现的有趣演变
Neurology. 2022 Aug 2;99(5):216-217. doi: 10.1212/WNL.0000000000200833. Epub 2022 Jun 2.
4
Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics.淀粉样相关影像学异常（ARIA）：影像学、生物学和临床特征。
Brain. 2023 Nov 2;146(11):4414-4424. doi: 10.1093/brain/awad188.
5
Teaching NeuroImage: CADASIL Mimicking Cerebral Amyloid Angiopathy-Related Inflammation.教学神经影像：酷似脑淀粉样血管病相关性炎症的大脑常染色体显性动脉病伴皮质下梗死和白质脑病
Neurology. 2024 Feb 27;102(4):e209155. doi: 10.1212/WNL.0000000000209155. Epub 2024 Jan 30.
6
Juxtacortical Lesion Precedes Lobar Microbleed During Anti-amyloid β Immunotherapy.在抗淀粉样蛋白β免疫治疗期间，皮质旁病变先于脑叶微出血出现。
Intern Med. 2025 May 15. doi: 10.2169/internalmedicine.5198-24.
7
Advancing Zr-immuno-PET in neuroscience with a bispecific anti-amyloid-beta monoclonal antibody - The choice of chelator is essential.利用双特异性抗淀粉样蛋白β单克隆抗体推进 Zr-免疫 PET 在神经科学中的应用 - 螯合剂的选择至关重要。
Theranostics. 2022 Oct 9;12(16):7067-7079. doi: 10.7150/thno.73509. eCollection 2022.
8
Novel anti-amyloid-beta (Aβ) monoclonal antibody lecanemab for Alzheimer's disease: A systematic review.新型抗淀粉样蛋白-β（Aβ）单克隆抗体 Lecanemab 治疗阿尔茨海默病的系统评价。
Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231209839. doi: 10.1177/03946320231209839.
9
Evaluating clinical meaningfulness of anti-β-amyloid therapies amidst amyloid-related imaging abnormalities concern in Alzheimer's disease.在阿尔茨海默病中存在淀粉样蛋白相关成像异常问题的情况下，评估抗β-淀粉样蛋白疗法的临床意义。
Brain Commun. 2024 Dec 3;6(6):fcae435. doi: 10.1093/braincomms/fcae435. eCollection 2024.
10
Amyloid-Related Imaging Abnormalities with Emerging Alzheimer Disease Therapeutics: Detection and Reporting Recommendations for Clinical Practice.淀粉样蛋白相关成像异常与新兴阿尔茨海默病治疗药物：临床实践中的检测和报告建议。
AJNR Am J Neuroradiol. 2022 Sep;43(9):E19-E35. doi: 10.3174/ajnr.A7586. Epub 2022 Aug 11.
本文引用的文献
1
Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics.淀粉样相关影像学异常（ARIA）：影像学、生物学和临床特征。
Brain. 2023 Nov 2;146(11):4414-4424. doi: 10.1093/brain/awad188.
2
Amyloid-Related Imaging Abnormalities with Emerging Alzheimer Disease Therapeutics: Detection and Reporting Recommendations for Clinical Practice.淀粉样蛋白相关成像异常与新兴阿尔茨海默病治疗药物：临床实践中的检测和报告建议。
AJNR Am J Neuroradiol. 2022 Sep;43(9):E19-E35. doi: 10.3174/ajnr.A7586. Epub 2022 Aug 11.
Zotero 插件